MDxHealth SA Stock Euronext Bruxelles
Equities
MDXH
BE0974461940
Biotechnology & Medical Research
Sales 2023 | 64.39M 68.68M | Sales 2024 * | 73.53M 78.42M | Capitalization | 63.67M 67.91M |
---|---|---|---|---|---|
Net income 2023 | -39M -41.6M | Net income 2024 * | -26M -27.73M | EV / Sales 2023 | 1.51 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.87 x |
P/E ratio 2023 |
-2.37
x | P/E ratio 2024 * |
-2.49
x | Employees | 255 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 97.37% |
Latest transcript on MDxHealth SA
1st Jan change | Capi. | |
---|---|---|
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |